AMBS OTC
Amarantus BioScience Holdings, Inc.
1W: +0.0%
1M: +9900.0%
3M: +0.0%
YTD: +900.0%
1Y: -66.7%
3Y: -88.9%
5Y: -99.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$10M
-30.6% ▼
5Y CAGR: -0.1%
Total Liabilities
$35M
+0.7% ▲
5Y CAGR: +4.3%
Shareholders Equity
-$25M
-23.8% ▼
Cash & Investments
$0
-100.0% ▼
Total Debt
$19M
-0.3% ▼
5Y CAGR: +12.4%
Net Debt
$19M
-0.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $829 | $708 | $46 | $708 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $829 | $708 | $46 | $708 | $0 |
| Net Receivables | $34K | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $31K | $31K | $31K | $31K |
| Total Current Assets | $755K | $31K | $31K | $31K | $31K |
| Property, Plant & Equip. | $0 | $0 | $0 | $0 | $0 |
| Goodwill & Intangibles | $1K | $1K | $1K | $1K | $1K |
| Long-Term Investments | $3M | $25M | $25M | $15M | $10M |
| Other Non-Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $3M | $25M | $25M | $15M | $10M |
| Total Assets | $3M | $25M | $25M | $15M | $10M |
| — Liabilities — | |||||
| Accounts Payable | $13M | $15M | $15M | $15M | $15M |
| Short-Term Debt | $19M | $19M | $19M | $19M | $19M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $0 | $0 | $424K |
| Total Current Liabilities | $31M | $34M | $34M | $35M | $35M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $31M | $34M | $34M | $35M | $35M |
| — Equity — | |||||
| Common Stock | $224K | $261K | $272K | $282K | $293K |
| Retained Earnings | -$116M | -$91M | -$91M | -$102M | -$106M |
| Accumulated OCI | -$224K | -$261K | -$272K | -$282K | -$293K |
| Total Stockholders Equity | -$28M | -$9M | -$9M | -$20M | -$25M |
| Total Liabilities & Equity | $3M | $25M | $25M | $15M | $10M |
| — Key Metrics — | |||||
| Total Debt | $19M | $19M | $19M | $19M | $19M |
| Net Debt | $19M | $19M | $19M | $19M | $19M |
| Total Investments | $3M | $25M | $25M | $15M | $10M |